Cargando…

Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option*

OBJECTIVE: Removal of cardiac autoantibodies by immunoadsorption might confer clinical improvement in dilated cardiomyopathy. In this pilot study, we investigated the efficacy and safety of immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy. METHODS: This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavusoglu, Yuksel, Tahmazov, Senan, Murat, Selda, Akay, Olga Meltem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Médica Brasileira 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937600/ https://www.ncbi.nlm.nih.gov/pubmed/36629647 http://dx.doi.org/10.1590/1806-9282.20220784

Ejemplares similares

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Immunoadsorption treatment for dilated cardiomyopathy: A PRISMA-compliant systematic review and meta-analysis
por: Bian, Ru-tao, et al.
Publicado: (2021)

Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19
por: Murat, Selda, et al.
Publicado: (2021)

Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy
por: Weinmann, Karolina, et al.
Publicado: (2019)

Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy
por: Ameling, Sabine, et al.
Publicado: (2013)

Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution
por: Ameling, Sabine, et al.
Publicado: (2016)

Erratum to: Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution
por: Ameling, Sabine, et al.
Publicado: (2017)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery
por: Ponzoni, Matteo, et al.
Publicado: (2023)

Immunoadsorption as maintenance therapy for refractory neuromyelitis optica spectrum disorder
por: Heigl, Franz, et al.
Publicado: (2023)

Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption
por: Yiğenoğlu, Tuğçe Nur, et al.
Publicado: (2020)

Genetics and genomics of dilated cardiomyopathy and systolic heart failure
por: Tayal, Upasana, et al.
Publicado: (2017)

Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis
por: Koziolek, Michael J, et al.
Publicado: (2012)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
por: Pfeuffer, Steffen, et al.
Publicado: (2022)

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
por: Dziewięcka, Ewa, et al.
Publicado: (2020)

Heart Failure and Importance of Collaboration of Professional Organizations: The Role of the Heart Failure Association of the European Society of Cardiology and Its Committee on National Heart Failure Societies
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2015)

Immunoadsorption Column Reuse
por: Tiwari, Vaibhav, et al.
Publicado: (2021)

Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy
por: Du, Cheng-Kun, et al.
Publicado: (2014)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Drug-refractory Heart Failure in Female Carrier of Duchenne Muscular Dystrophy: A Case of X-linked Dilated Cardiomyopathy
por: Ohtani, Hayato, et al.
Publicado: (2022)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Prevalence of Anemia in Children with Congestive Heart Failure due to Dilated Cardiomyopathy
por: Mueller, Goetz Christoph, et al.
Publicado: (2012)

Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression
por: Bogomolovas, Julius, et al.
Publicado: (2015)

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
por: Farinha, Inês Teixeira, et al.
Publicado: (2016)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column—A prospective, multicenter, randomized, within‐patient and parallel‐group comparative study to evaluate efficacy and safety
por: Yoshikawa, Tsutomu, et al.
Publicado: (2016)

Immunoadsorption therapy in autoimmune encephalitides
por: Dogan Onugoren, Müjgan, et al.
Publicado: (2016)

Immunoadsorption and covid 19 pandemic
por: Tseke, Paraskevi, et al.
Publicado: (2022)

Mitral valve replacement in dilated cardiomyopathy: A valid option?
por: Mashali, Mohamed Hesham, et al.
Publicado: (2020)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence
por: Gonzalez-Valdes, I., et al.
Publicado: (2015)

Identification of Potential Gene Interactions in Heart Failure Caused by Idiopathic Dilated Cardiomyopathy
por: Huang, Huijuan, et al.
Publicado: (2018)

Immune-inflammatory concept of the pathogenesis of chronic heart failure in dogs with dilated cardiomyopathy
por: Vatnikov, Yu, et al.
Publicado: (2019)

Nemaline myopathy with dilated cardiomyopathy and severe heart failure: A case report
por: Wang, Qian, et al.
Publicado: (2021)

Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
por: Rakusiewicz, Klaudia, et al.
Publicado: (2021)

Dilated Cardiomyopathy and Systolic Heart Failure in a Female Patient With Danon Disease
por: Stack-Pyle, Taylor J, et al.
Publicado: (2022)

The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy
por: Makarewich, Catherine A, et al.
Publicado: (2018)

Glucagonoma-associated dilated cardiomyopathy refractory to somatostatin analogue therapy
por: Barabas, Michal, et al.
Publicado: (2019)

CMRI morphological and functional changes of the heart in myocarditis and dilated cardiomyopathy in acute pediatric heart failure
por: Kharabish, Ahmed E
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8fafpkmv69gk7k79vi1e3ir403